Salix Pharmaceuticals, Ltd. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2014-12-31 9 months ending 2014-09-30 3 months ending 2014-06-30 3 months ending 2014-03-31 3 months ending 2013-12-31
Revenue 13.48 1,120.07 375.54 402.98 237.56
Other Revenue, Total - - - - -
Total Revenue 13.48 1,120.07 375.54 402.98 237.56
Cost of Revenue, Total 30.22 307.62 104.57 116.94 55.32
Gross Profit -16.74 812.45 270.97 286.04 182.24
Selling/General/Admin. Expenses, Total 137.07 523.04 138.36 207.10 118.57
Research & Development 66.81 103.48 25.58 41.22 -0.94
Depreciation/Amortization 54.25 161.85 53.91 53.90 11.23
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) 148.56 90.74 10.15 4.04 -23.20
Other Operating Expenses, Total - - - - -
Total Operating Expense 436.92 1,186.72 332.56 423.20 160.97
Operating Income -423.44 -66.66 42.98 -20.22 76.58
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net - - - - -
Income Before Tax -467.33 -196.26 0.51 -62.62 61.49
Income After Tax -287.64 -127.27 0.42 -34.58 40.04
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items -287.64 -127.27 0.42 -34.58 40.04
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income -287.64 -127.27 0.42 -34.58 40.04
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items -287.64 -127.27 0.42 -34.58 40.04
Income Available to Common Incl. Extra Items -287.64 -127.27 0.42 -34.58 40.04
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment 0.00 0.00 0.00 0.00 0.00
Diluted Weighted Average Shares 63.75 63.65 75.45 63.32 67.67
Diluted EPS Excluding Extraordinary Items -4.51 -2.00 0.01 -0.55 0.59
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS -3.00 -1.07 0.12 -0.50 0.37